Interest Coverage Ratio: 20.98x
Is the interest coverage ratio high or low?
The interest coverage ratio of 20.98x is 143% above its 5-year average of 8.65x, near the high end of its 5-year range (-11.50x–20.98x).
As of Friday, June 26, 2026. 22.87% above its 12-month average of 17.08x.
STE Interest Coverage Ratio
Reported quarterly interest coverage; no daily interpolation.
STE Average Interest Coverage Ratio Chart
STE Current vs Average Interest Coverage Ratio Chart
STE Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
20.98x
INTEREST COVERAGE RATIO AVG TTM
17.08x
INTEREST COVERAGE RATIO AVG 3Y
11.30x
INTEREST COVERAGE RATIO AVG 5Y
9.65x
INTEREST COVERAGE RATIO AVG 10Y
9.70x
INTEREST COVERAGE RATIO AVG 15Y
10.81x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+22.87%
CURRENT VS 3Y AVG
+85.74%
CURRENT VS 5Y AVG
+117.34%
CURRENT VS 10Y AVG
+116.24%
CURRENT VS 15Y AVG
+94.00%
CURRENT VS 20Y AVG
N/A
STE Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $21.00B | 20.98x | 17.08x | 11.30x | 9.65x |
| Labcorp Holdings Inc. (LH)vs › | $22.26B | 6.77x | 5.99x | 5.91x | 8.30x |
| Incyte Corporation (INCY)vs › | $22.73B | 553.04x | 298.73x | 269.07x | 276.66x |
| Viatris Inc. (VTRS)vs › | $19.02B | -5.65x | 0.68x | 1.36x | 1.37x |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 77.81x | 54.95x | 40.03x | 35.88x |
| BioNTech SE (BNTX)vs › | $23.07B | -45.74x | 444.02x | 1201.03x | 1201.03x |
| Quest Diagnostics Incorporated (DGX)vs › | $23.08B | 5.79x | 5.88x | 7.29x | 9.45x |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.01B | 4.65x | 5.28x | 5.28x | 4.27x |
| Waters Corporation (WAT)vs › | $24.41B | 12.84x | 11.03x | 12.05x | 13.28x |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.79B | 1029.00x | 617.01x | 353.82x | 258.97x |
Financial Health Indicators
Interest Coverage
21.0x
Debt/Equity
0.29
Current Ratio
2.09
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Interest Coverage Ratio FAQ
- What is the interest coverage ratio for STERIS plc (STE)?
- The interest coverage ratio for STE stock is 20.98x.
- Is STERIS plc's interest coverage ratio high or low?
- The interest coverage ratio of 20.98x is 143% above its 5-year average of 8.65x, near the high end of its 5-year range (-11.50x–20.98x).
- What is the TTM average interest coverage ratio for STERIS plc (STE)?
- The TTM average interest coverage ratio for STE stock is 17.08x.
- What is the 3Y average interest coverage ratio for STERIS plc (STE)?
- The 3Y average interest coverage ratio for STE stock is 11.30x.
- What is the 5Y average interest coverage ratio for STERIS plc (STE)?
- The 5Y average interest coverage ratio for STE stock is 9.65x.
- What is the 10Y average interest coverage ratio for STERIS plc (STE)?
- The 10Y average interest coverage ratio for STE stock is 9.70x.
- What is the 15Y average interest coverage ratio for STERIS plc (STE)?
- The 15Y average interest coverage ratio for STE stock is 10.81x.
STE Interest Coverage Ratio History
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 20.98x |
| 2025-12-31 | 18.31x |
| 2025-09-30 | 17.99x |
| 2025-06-30 | 15.47x |
| 2025-03-31 | 12.63x |
| 2024-12-31 | 12.85x |
| 2024-09-30 | 11.17x |
| 2024-06-30 | 6.10x |
| 2024-03-31 | 6.79x |
| 2023-12-31 | 5.81x |
| 2023-09-30 | 5.19x |
| 2023-06-30 | 6.11x |
| 2023-03-31 | 7.44x |
| 2022-12-31 | 6.26x |
| 2022-09-30 | -11.50x |
| 2022-06-30 | 6.76x |
| 2022-03-31 | 4.22x |
| 2021-12-31 | 8.83x |
| 2021-09-30 | 5.06x |
| 2021-06-30 | 0.66x |
| 2021-03-31 | 14.43x |
| 2020-12-31 | 16.52x |
| 2020-09-30 | 16.30x |
| 2020-06-30 | 12.20x |
| 2020-03-31 | 16.18x |
| 2019-12-31 | 14.51x |
| 2019-09-30 | 12.13x |
| 2019-06-30 | 10.31x |
| 2019-03-31 | 12.81x |
| 2018-12-31 | 5.88x |
| 2018-09-30 | 9.35x |
| 2018-06-30 | 8.04x |
| 2018-03-31 | 8.73x |
| 2017-12-31 | 8.29x |
| 2017-09-30 | 7.77x |
| 2017-06-30 | 6.85x |
| 2017-03-31 | 5.08x |
| 2016-12-31 | 2.36x |
| 2016-09-30 | 6.37x |
| 2016-06-30 | 6.64x |
| 2016-03-31 | 8.72x |
| 2015-12-31 | 2.64x |
| 2015-09-30 | 3.03x |
| 2015-06-30 | 7.22x |
| 2015-03-31 | 14.42x |
| 2014-12-31 | 12.72x |
| 2014-09-30 | 10.80x |
| 2014-06-30 | 9.43x |
| 2014-03-31 | 14.05x |
| 2013-12-31 | 11.96x |
| 2013-09-30 | 10.33x |
| 2013-06-30 | 8.22x |
| 2013-03-31 | 12.66x |
| 2012-12-31 | 15.96x |
| 2012-09-30 | 18.28x |
| 2012-06-30 | 16.25x |
| 2012-03-31 | 24.83x |
| 2011-12-31 | 17.88x |
| 2011-09-30 | 15.46x |
| 2011-06-30 | 15.11x |
| 2011-03-31 | 19.50x |
| 2010-12-31 | 11.75x |
| 2010-09-30 | 18.33x |
| 2010-06-30 | -20.95x |
| 2010-03-31 | 14.01x |
| 2009-12-31 | 18.06x |
| 2009-09-30 | 16.00x |
| 2009-06-30 | 13.90x |
| 2008-12-31 | 14.26x |
| 2008-09-30 | 18.65x |
| 2008-06-30 | 19.84x |
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Daniel A. Carestio